Clinical Trials Directory

Trials / Sponsors / Arno Therapeutics

Arno Therapeutics

Industry · 6 registered clinical trials.

StatusTrialPhaseStarted
UnknownPhase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Prostate Cancer, Metastatic Prostate Cancer, Androgen-independent Prostate Cancer
Phase 1 / Phase 22014-02-01
UnknownPhase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers
Progesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapy
Phase 1 / Phase 22014-01-01
UnknownStudy of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Glioblastoma Multiforme, GBM, Gliosarcoma
Phase 22009-12-01
CompletedStudy of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in A
Solid Tumors, Lymphoma
Phase 12009-08-01
UnknownStudy of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)
Myelodysplastic Syndrome
Phase 22009-06-01
CompletedStudy of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies
Tumors
Phase 12006-10-01